Biostatistician, Health Technology Assessment

We are a research-driven biopharmaceutical company. Our mission is built on the simple premise that if we “follow the science” and that great medicines can make a significant impact to our world. And we believe that a research-driven enterprise dedicated to world-class science can succeed by inventing medicine and vaccine innovations that make a difference for patients across the globe.

The Biostatistics and Research Decision Sciences (BARDS) organization has a proud record of providing comprehensive analytical and methodological expertise to support our company’s strategic goals. Our quantitative scientists aspire to maintain the highest quality output while adopting the most efficient and effective scientific and operational procedures that will promote breakthrough innovation, collaboration and professional activity.

We are currently looking for a Biostatistician, HTA Statistics (full-time, indefinite) to join the team based in our new office in Zürich.

The BARDS organization has established in Europe its Centre of Excellence supporting Health Technology Assessment (HTA) dossiers. Our statisticians and statistical programmers collaborate with multiple functional areas across the company and with our local affiliates to ensure that the clinical trial data representing our products is characterized properly in these dossiers, and to develop innovative statistical approaches to novel problems in the HTA space.

**The primary activities include but are not limited to**:
Provide statistical support to projects in the BARDS HTA Statistics group, including HTA submissions.
Contribute to the design and development of scientific tools for HTA evaluations.
Execute on ongoing HTA evaluations, including analysis and interpretation of HTA results.
Collaborate with Statistical Programming to implement methodologies and ensure high quality deliverables for HTA submissions.
Contribute to the preparation of the written reports to effectively communicate results of HTA evaluations to the Centre for Observational and Real-World Evidence (CORE) and our company’s subsidiary teams.
May evaluate appropriateness of available software for planned analyses and ascertains needs for potential program development of novel statistical methodology.

**Qualifications**:
Master’s degree or bachelor’s degree in statistics or a related quantitative field,
Fluency in English (oral and written).
Good knowledge of biostatistical methodologies and experimental design, including meta-analyses and time to event methodologies.
Understanding of data management and clinical concepts applied to drug development within the pharmaceutical industry.
Proven knowledge of statistical and data processing software e.g. SAS and/or R.
Team oriented, strong collaboration skills and ability to work effectively across cultures.
Must also demonstrate the ability to learn, be proactive and motivated, and consistently focus on details and execution.

Our Quantitative Sciences team use big data to analyse the safety and efficacy claims of our potential medical breakthroughs. We review the quality and reliability of clinical studies using deep scientific knowledge, statistical analysis and high-quality data to support decision making in clinical trials.

THE COMPANY

Our Company has had a presence in Switzerland since 1963. With a regional office and manufacturing/packaging facility, Lucerne is considered the centre of operations. Approximately 1,000 people work collaboratively at the four Lucerne locations (Weystrasse, Citybay, Schachen and Kriens). A fifth location has been recently established in Zurich, aimed at accelerating the development and commercialization of many of our company’s medicines and vaccines, which supports our mission to save and improve lives around the world. The new location has a target date of 2021 for operational readiness.

We are proud to be certified as a “Top Employer Switzerland” and “Top Employer Europe” showing the company’s commitment to our employees and the community around us.

Zurich
The recently opened new location in Zurich focuses on accelerating research, data and commercialization of our medicines and vaccines. The new office will be staffed by teams working in strategic and operational roles in medical affairs, clinical development, access and marketing operations functions.

Who we are

Merck & Co., Inc., Kenilworth, New Jersey, USA is known as “Merck” in the United States, Canada & Puerto Rico. We are known as “MSD” in Europe, Middle East, Africa, Latin America & Asia Pacific. We are a global biopharmaceutical leader with a diverse portfolio of prescription medicines, oncology, vaccines and animal health products.
We are driven by our purpose to develop and deliver innovative products that save and improve lives. With 69,000 employees operating in more than 140 countries, we offer state of the art laboratories, plants and offices that are designed to Inspire our employees as we lear